Literature DB >> 17243970

Successful treatment of oral erosive lichen planus with mycophenolate mofetil.

J Dalmau, L Puig, E Roé, L Peramiquel, M Campos, A Alomar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17243970     DOI: 10.1111/j.1468-3083.2006.01832.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  7 in total

1.  The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room.

Authors:  Hyunhee Park
Journal:  J Clin Aesthet Dermatol       Date:  2011-01

2.  Treatment of oral lichen planus with mucoadhesive mycophenolate mofetil patch: A randomized clinical trial.

Authors:  Negin Samiee; Ali Taghavi Zenuz; Masumeh Mehdipour; Javad Shokri
Journal:  Clin Exp Dent Res       Date:  2020-06-26

Review 3.  Therapeutic strategies for oral lichen planus: State of the art and new insights.

Authors:  Dario Didona; Raffaele Dante Caposiena Caro; Antonio Manuel Sequeira Santos; Farzan Solimani; Michael Hertl
Journal:  Front Med (Lausanne)       Date:  2022-10-04

4.  Dermatology for the allergist.

Authors:  Dennis Kim; Richard Lockey
Journal:  World Allergy Organ J       Date:  2010-06-15       Impact factor: 4.084

5.  Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus.

Authors:  Sinny Goel; Akanksha Marwah; Smita Kaushik; Vijay K Garg; Sunita Gupta
Journal:  J Clin Exp Dent       Date:  2015-10-01

Review 6.  Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19.

Authors:  Heba Hussein; Ronald Brown
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2020-06-20

7.  Effects of Mycophenolate Mofetil, Methotrexate and Pimecrolimus on cdk4 and p16 in Erosive Oral Lichen Planus.

Authors:  Sinny Goel; Nita Khurana
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.